We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MI

News List

Farxiga Granted Fast Track Designation for Heart Failure Following Acute Myocardial Infarction americanpharmaceuticalreview
July 24, 2020
AstraZeneca has been granted Fast Track Designation in the US for the development of Farxiga (dapagliflozin) to reduce the risk of hospitalization for heart failure (hHF) or cardiovascular (CV) death in adults following an acute myocardial infarction ...
Machine Learning Model Helps Predict Risk for MI, Cardiac Death drugs
December 30, 2019
A machine learning (ML) model improves the prediction of long-term risks for myocardial infarction (MI) and cardiac death ...
Guidance Issued for Research Use of Cardiac MRI After MI drugs
August 06, 2019
In a scientific expert panel consensus document, published in the July 16 issue of the Journal of the American College of Cardiology...